| Literature DB >> 29643424 |
Kamelia M Osman1, Anthony D Kappell2, Mohamed Elhadidy3,4, Fatma ElMougy5, Wafaa A Abd El-Ghany6, Ahmed Orabi7, Aymen S Mubarak8, Turki M Dawoud8, Hassan A Hemeg9, Ihab M I Moussa8, Ashgan M Hessain10, Hend M Y Yousef11.
Abstract
Hatcheries have the power to spread antimicrobial resistant (AMR) pathogens through the poultry value chain because of their central position in the poultry production chain. Currently, no information is available about the presence of AMR Escherichia coli strains and the antibiotic resistance genes (ARGs) they harbor within hatchezries. Therefore, this study aimed to investigate the possible involvement of hatcheries in harboring hemolytic AMR E. coli. Serotyping of the 65 isolated hemolytic E. coli revealed 15 serotypes with the ability to produce moderate biofilms, and shared susceptibility to cephradine and fosfomycin and resistance to spectinomycin. The most common β-lactam resistance gene was blaTEM, followed by blaOXA-1, blaMOX-like, blaCIT-like, blaSHV and blaFOX. Hierarchical clustering of E. coli isolates based on their phenotypic and genotypic profiles revealed separation of the majority of isolates from hatchlings and the hatchery environments, suggesting that hatchling and environmental isolates may have different origins. The high frequency of β-lactam resistance genes in AMR E. coli from chick hatchlings indicates that hatcheries may be a reservoir of AMR E. coli and can be a major contributor to the increased environmental burden of ARGs posing an eminent threat to poultry and human health.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29643424 PMCID: PMC5895583 DOI: 10.1038/s41598-018-23962-7
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Number of E. coli isolates per matrix and hatchery.
| Sampled Matrices | Hatcheries (H) | Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| H1 | H2 | H3 | H4 | H5 | H6 | H7 | H8 | H9 | H10 | ||
| Day-old hatchling meconium | 4/45 | 4/45 | 4/45 | 5/45 | 3/45 | 5/45 | 5/45 | 0/45 | 0/45 | 0/45 | 30/450 |
| Air tunnels | 0/3 | 0/3 | 0/3 | 1/3 | 0/3 | 1/3 | 1/3 | 0/3 | 0/3 | 0/3 | 3/30 |
| Incubators | 0/3 | 0/3 | 3/3 | 1/3 | 1/3 | 1/3 | 1/3 | 0/3 | 0/3 | 0/3 | 7/30 |
| Hatchery machines | 0/3 | 0/3 | 2/3 | 1/3 | 0/3 | 1/3 | 1/3 | 0/3 | 0/3 | 0/3 | 5/30 |
| Infertile eggs | 2/3 | 2/3 | 0/3 | 1/3 | 0/3 | 1/3 | 1/3 | 0/3 | 0/3 | 0/3 | 7/30 |
| Water | 0/3 | 2/3 | 1/3 | 0/3 | 1/3 | 0/3 | 0/3 | 0/3 | 0/3 | 0/3 | 4/30 |
| Workers’ hands | 1/3 | 1/3 | 0/3 | 0/3 | 1/3 | 0/3 | 0/3 | 0/3 | 0/3 | 0/3 | 3/30 |
| Egg refrigerators | 0/3 | 1/3 | 0/3 | 1/3 | 0/3 | 1/3 | 0/3 | 0/3 | 0/3 | 0/3 | 3/30 |
| Floors | 0/3 | 1/3 | 0/3 | 1/3 | 0/3 | 1/3 | 0/3 | 0/3 | 0/3 | 0/3 | 3/30 |
| Total | 7/69 | 11/69 | 10/69 | 11/69 | 6/69 | 11/69 | 9/69 | 0/69 | 0/69 | 0/69 | |
H1–H10 = Hatcheries 1 to 10; Hatchery samples were obtained from two visits. A total of 45 hatchling samples and 3 samples per environmental site were obtained per a hatchery.
Number of E. coli isolates/number of samples (percentage of isolates).
Phenotypes and genotypes identified as significantly different (p < 0.05) between the source of isolation (hatchlings vs. hatchery environments).
| Phenotypes | Source | Prevalence (%) | |
|---|---|---|---|
| Ciprofloxacin (R) | Hatchery environment | 62.9 | 0.008 |
| Chicken hatchlings | 30 | ||
| Hatchery environment | 14.3 | 0.019 | |
| Chicken hatchlings | 40 | ||
| Hatchery environment | 88.6 | 0.008 | |
| Chicken hatchlings | 60 | ||
| Hatchery environment | 11.4 | <0.001 | |
| Chicken hatchlings | 90 | ||
| Hatchery environment | 0 | 0.001 | |
| Chicken hatchlings | 26.7 | ||
| Hatchery environment | 8.6 | <0.001 | |
| Chicken hatchlings | 66.7 | ||
| CR (+) | Hatchery environment | 8.6 | 0.009 |
| Chicken hatchlings | 36.7 | ||
| CR (+++) | Hatchery environment | 31.4 | 0.009 |
| Chicken hatchlings | 10 |
List, classification and prioritization of antimicrobials categorized as critically important in human and veterinary medicine.
| Antibiotic | Disc concentration | Antimicrobial class | Medical importance (53) | Prioritization criterion |
|---|---|---|---|---|
| Colistin | 600 µg | Polymyxins | Highest Priority Critically Important Antimicrobials | P1, P2 and P3 |
| Cephradine | 10 µg | Cephalosporins | Highly Important Antimicrobials | NA |
| Ceftiofur | 10 µg | Cephalosporins | Highest Priority Critically Important Antimicrobials | P1, P2 and P3 |
| Fosfomycin | 5 µg | Phosphonic acid derivatives | High Priority Critically Important Antimicrobials | P1 and P2 |
| Gentamycin | 20 µg | Aminoglycosides | High Priority Critically Important Antimicrobials | P2 and P3 |
| Neomycin | 30 µg | Aminoglycosides | High Priority Critically Important Antimicrobials | P2 and P3 |
| Streptomycin | 5 µg | Aminoglycosides | High Priority Critically Important Antimicrobials | P2 and P3 |
| Chloramphenicol | 15 µg | Amphenicols | Highly Important Antimicrobials | NA |
| Enrofloxacin | 10 µg | Quinolones and fluoroquinolones | Highest Priority Critically Important Antimicrobials | P1, P2 and P3 |
| Ciprofloxacin | 10 µg | Quinolones and fluoroquinolones | Highest Priority Critically Important Antimicrobials | P1, P2 and P3 |
| Norfloxacin | 10 µg | Quinolones and fluoroquinolones | Highest Priority Critically Important Antimicrobials | P1, P2 and P3 |
| Flumequine | 5 µg | Quinolones and fluoroquinolones | Highest Priority Critically Important Antimicrobials | P1, P2 and P3 |
| Pefloxacin | 5 µg | Quinolones and fluoroquinolones | Highest Priority Critically Important Antimicrobials | P1, P2 and P3 |
| Amoxicillin | 10 µg | Penicillins | Highest Priority Critically Important Antimicrobials | P2 and P3 |
| Ampicillin | 10 µg | Penicillins | Highest Priority Critically Important Antimicrobials | P2 and P3 |
| Sulfamethoxazole/Trimethoprim | 15 µg | Sulfonamides, dihydrofolate reductase inhibitors combination | Highly Important Antimicrobials | NA |
| Spiramycin | 5 µg | Macrolides and ketolides | Highest Priority Critically Important Antimicrobials | P1, P2 and P3 |
| Erythromycin | 20 µg | Macrolides and ketolides | Highest Priority Critically Important Antimicrobials | P1, P2 and P3 |
| Spectinomycin | 5 µg | Aminocyclitols | Important Antimicrobials | NA |
| Rifampicin | 5 µg | Ansamycins | Highest Priority Critically Important Antimicrobials | P1 and P2 |
| Oxytetracyclin | 20 µg | Tetracyclines | Highly Important Antimicrobials | NA |
| Doxycycline | 20 µg | Tetracyclines | Highly Important Antimicrobials | NA |
| Clindamycin | 20 µg | Lincosamides | Highly Important Antimicrobials | NA |
Prioritization criterion 1 (P1): High absolute number of people, or high proportion of use in patients with serious infections in health care settings affected by bacterial diseases for which the antimicrobial class is the sole or one of few alternatives for treating serious infections in humans. Prioritization criterion 2 (P2): High frequency of use of the antimicrobial class for any indication in human medicine, or high proportion of use in patients with serious infections in health care settings, because use may favor selection of resistance in both settings. Prioritization criterion 3 (P3): The antimicrobial class is used to treat infections in people for whom there is evidence of transmission of resistant bacteria (e.g., non-typhoidal Salmonella and Campylobacter spp.) or resistance genes (high for E. coli and Enterococcus spp.) from non-human sources. NA: not available.
Figure 1Biofilm formation in the microtiter plate assay by serotype.
Figure 2Correlation matrix of phenotypic (antibiotic resistance, hemolytic activity and biofilm formation ability) and genotypic (antibiotic resistance genes) features showing significant (p < 0.05) correlations. White spaces are not significantly correlated. Blue circles indicated significant positive correlation and red show significant negative correlation. The size and strength of color represent the numerical value of the Phi correlation coefficient.
Figure 3Heatmap and hierarchical clustering of E. coli isolates according to their phenotypic (antibiotic resistance) and genotypic (antibiotic resistance genes) profile of variables showing differences between isolates. Red represent presence and green represented absence of resistance or gene. Left of the heatmap is color representation of the different sources (hatchling in green and hatchery in red), the different serotypes, and the different hatcheries. Hierarchical clustering was perform using Wald’s method and a binary distance matrix. Letters designate the 3 main clusters described in the text.
Figure 4Principle component analysis performed on variables showing differences. (A) Visualization of the isolates encompassed in 95% confidence intervals grouping based on source of the isolate (hatchery or hatchling) and (B) labeling of the individual isolates from the same analysis.
PCR-specific oligonucleotide primers, amplicon size and conditions for uidA, ampC and class A β-lactamase genes.
| Name | Target Enzyme(s) | Amplicon Size (bp) | Cycle Number | Annealing Temperature (°C) | Primer Sequence | Conferred Resistance (or Purpose) | Reference |
|---|---|---|---|---|---|---|---|
|
| β-glucuronidase specific for | 486 | 35 | 60 | P1: 5′-ATCACCGTGGTGACGCATGTCGC | Confirmation of |
[ |
| P2: 5′-CACCACGATGCCATGTTCATCTGC | |||||||
| AmpC-like β-lactamase (plasmid associated) | |||||||
| MOX-1, MOX-2, CMY-1, CMY-8 to CMY-11 | 520 | 25 | 64 | MOXMF: 5′-GCTGCTCAAGGAGCACAGGAT | Enzymes are known to confer resistance to penicillins, oxyimino group cephalosporins and 7-α-methoxy group. Possible resistance to monobactam aztreonam. Unchanged sensitivity for cefepime and carbapenems[ |
[ | |
| MOXMR: 5′-CACATTGACATAGGTGTGGTGC | |||||||
| LAT-1 to LAT-4, CMY-2 to CMY-7, BIL-1 | 462 | 25 | 64 | CITMF: 5′-TGGCCAGAACTGACAGGCAAA | |||
| CITMR: 5′-TTTCTCCTGAACGTGGCTGGC | |||||||
|
| FOX-1 to FOX-5b | 190 | 25 | 64 | FOXMF: 5′-AACATGGGGTATCAGGGAGATG | ||
| FOXMF: 5′-CAAAGCGCGTAACCGGATTGG | |||||||
| Extended-spectrum β-lactamase (plasmid associated) | |||||||
|
| OXA-1 | 609 | 54 | 32 | OXA-G: 5′-TCAACTTTCAAGATCGCA | ESBL enzymes retain ability to confer resistance to penicillins and confer resistance to expanded-spectrum cephalosporins. Unchanged sensitivity for cephamycins, cefoxitin, and cefotetan[ |
[ |
| OXA-H: 5′-GTGTGTTTAGAATGGTGA | |||||||
|
| SHV | 392 | 54 | 32 | SHV-F: 5′-AGGATTGACTGCCTTTTTG | ||
| SHV-R: 5′-ATTTGCTGATTTCGCTCG | |||||||
|
| TEM | 516 | 54 | 32 | TEM-C: 5′-ATCAGCAATAAACCAGC | ||
| TEM-H: 5′-CCCCGAAGAACGTTTTC | |||||||